All In Biotech

Free tool

FAERS Monitor: Uzedy

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 213586 or its brand name (Uzedy, Risperidone). Reports on generic versions are filed under their own applications.

Reports

64,028

Serious

49,562

77% of reports

Hospitalization

23,736

Death reported

5,886

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • gynaecomastia9,330
  • off label use5,729
  • drug ineffective5,316
  • weight increased4,408
  • drug interaction3,245
  • product use in unapproved indication2,988
  • emotional disorder2,879
  • abnormal weight gain2,864
  • condition aggravated2,411
  • somnolence2,323
  • toxicity to various agents2,293
  • extrapyramidal disorder2,091
  • emotional distress1,959
  • suicide attempt1,898
  • anxiety1,859

Reports by year received

View as table
YearReports
2004400
2005506
2006592
2007580
2008698
20091,200
20101,157
20111,587
20121,884
20131,528
20141,923
20154,815
20164,930
20176,885
20184,496
20194,735
20204,062
20213,694
20223,744
20233,527
20243,981
20253,972
20263,131

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 20,990,131 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
gynaecomastiaSignal9,330141.4138.1909,748
abnormal weight gainSignal2,86498.894.8213,140
emotional disorderSignal2,87933.732.583,016
extrapyramidal disorderSignal2,09130.128.853,932
suicide attemptSignal1,89810.610.115,990
drug interactionSignal3,2456.86.615,960
weight increasedSignal4,4086.66.420,644
emotional distressSignal1,9595.45.26,920
toxicity to various agentsSignal2,2934.54.36,235
product use in unapproved indicationSignal2,9884.03.96,708
somnolenceSignal2,3233.83.74,829
condition aggravatedSignal2,4112.62.52,425
off label useSignal5,7292.22.13,684
anxietySignal1,8592.22.11,155
drug ineffective5,3161.31.3453

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.